Close Menu

imatinib

Is Imatinib Protective Against to Osteoporosis? - A Comparative Study in Terms of Bone Densitometry on Chronic Myeloid Leukaemia Patients and Healthy Volunteers

DOI: 
10.7727/wimj.2015.447
Synopsis: 
Previous studies have shown that imatinib affects bone metabolism in chronic myeloid leukemia (CML) patients. We aimed in this study to investigate whether the inhibition of tyrosine kinase is a new potential target against osteoporosis which is an important issue for public health.

ABSTRACTS

Accepted: 
08 Sep, 2015
PDF Attachment: 
Journal Sections: 
e-Published: 12 Feb, 2016

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Five Year Follow-up of Patients Treated with Imatinib Mesylate for Chronic Myeloid Leukaemia in Trinidad and Tobago

Issue: 
Pages: 
298–302
Synopsis: 
The delivery of quality pharmacy services is thought to be important by virtue of its influence on patient’s satisfaction and hence better patient compliance/adherence. This study explores the relationship between patient’s satisfaction with pharmacy services and control of selected chronic diseases. General Hospital is presented. Efficacy, safety and tolerability seem comparable to that reported in developed countries.

ABSTRACT

Objective: Data on the use of Imatinib (IM) in developing countries remain limited. A retrospective study was done to assess the efficacy and toxicity of IM in treating chronic myeloid leukaemia (CML) in Trinidad and Tobago.

PDF Attachment: 
Journal Sections: 
e-Published: 31 Jan, 2014
Subscribe to RSS - imatinib
Top of Page